Hanlon Suzanne M. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jan 28, 2019
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-01-24+52,859→ 52,859 totalExercise: $3.65Exp: 2029-01-24→ Common Stock (52,859 underlying)
Footnotes (1)
- [F1]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company.